Search

Your search keyword '"Marc L. Citron"' showing total 69 results

Search Constraints

Start Over You searched for: Author "Marc L. Citron" Remove constraint Author: "Marc L. Citron"
69 results on '"Marc L. Citron"'

Search Results

1. Measurement of differential tt¯ production cross sections in the full kinematic range using lepton+jets events from proton-proton collisions at s=13 TeV

2. Measurement of the top quark mass in the all-jets final state at $$\sqrt{s}=13\,\text {TeV} $$ s = 13 TeV and combination with the lepton+jets channel

3. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

4. Exploration of communication gaps among women with metastatic breast cancer, caregivers and oncologists

5. Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

6. Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey

7. Abstract P1-11-06: The experience of caregivers of women with metastatic breast cancer: Insights from the Make Your Dialogue Count survey

8. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

9. Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy As (neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer

10. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

11. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

12. Abstract P2-15-03: Cardiac safety of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive (HER2+) early-stage breast cancer (EBC): Final data from TDM4874g

13. Abstract P2-10-01: PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy

14. Isolated Sternal Involvement in Breast Cancer: Is it Truly Stage IV Disease?

15. Is there a role for older-patient-specific cancer clinical trials? A pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715)

16. Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives

17. Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

18. Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)

19. Dose Density in Adjuvant Chemotherapy for Breast Cancer

20. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

21. Predicting response and survival in chemotherapy-treated triple-negative breast cancer

22. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain

23. Dihydro-5-azacytidine in malignant mesothelioma

24. Intracellular localization and intercellular heterogeneity of the human DNA repair protein O 6 -methylguanine-DNA methyltransferase

25. In Reply

26. Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?

27. P53 protein overexpression in lung adenocarcinomas in non-smokers

28. A Phase II Trial of Concomitant Human Interleukin-2 and Interferon-??-2a in Patients with Disseminated Malignant Melanoma

29. O6-Methylguanine-DNA Methyltransferase in Human Normal and Malignant Lung Tissues

30. Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study

31. Continuous Intravenous Infusion of Morphine for Severe Dyspnea

32. Emotional experiences of oncologists treating women with metastatic breast cancer (MBC)

33. Doctor-patient perceptions and discourse on side effects related to metastatic breast cancer (MBC) treatment: The Make Your Dialogue Count survey

34. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York

35. Lung Cancer Risk in White and Black Americans

36. 413 Relationship Between Body Mass Index (BMI) and Outcomes in Node-positive Breast Cancer Patients Receiving Chemotherapy–Results From CALGB/Intergroup 9741

37. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer

38. Understanding potential communication gaps between oncologists and patients with advanced breast cancer: A survey of oncologists

39. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study

40. A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain

41. Body mass index (BMI), tumor subtype, and relapse-free survival (RFS) in CALGB 9741 (Alliance)

42. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281

43. Cardiac safety in a phase II study of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-positive breast cancer

44. Adjuvant therapy for breast cancer

45. 5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin

46. O6-methylguanine-DNA methyltransferase in normal and malignant tissue of the breast

47. Detection of messenger RNA from O6-methylguanine-DNA methyltransferase gene MGMT in human normal and tumor tissues

48. Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use

50. Toxicity of older and younger patients (pts) treated (Rx) with intensive adjuvant chemotherapy (Cx) for node-positive (N+) breast cancer (BC): The CALGB experience

Catalog

Books, media, physical & digital resources